Home / SMSPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SMSPHARMA.NS make money? Does SMSPHARMA.NS have pricing power? What's the Earnings Whisper? Will SMSPHARMA.NS profit more as the business scales? What is SMSPHARMA.NS's management track record? Is SMSPHARMA.NS's current price justified?

SMS Pharmaceuticals Limited

₹450.5 +$137.05 (+43.72%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹424.95

Day Range

₹423.2₹458.5

Year Range

₹270.1₹494.45

Market Cap

42.19B

AVG Volume

617.83K

Trailing/Forward PE

40.08/-

PEG ratio

1.26

Dividend Yield

0.09%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

SMSPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	8.87B
2025	7.83B
2024	7.09B
2023	5.22B
2022	5.15B
2021	5.61B
2020	4.07B
2019	4.62B
2017	3.24B
2016	6.03B

Net Income (INR) · A

SMSPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	1.02B
2025	691.36M
2024	498.26M
2023	-75M
2022	619.62M
2021	625.27M
2020	316.62M
2019	400.49M
2017	204.76M
2016	408.92M

Operating Income (INR) · A

SMSPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	1.31B
2025	1.05B
2024	876.51M
2023	260.22M
2022	819.19M
2021	984.3M
2020	581.45M
2019	708.73M
2017	410.05M
2016	713.29M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

SMS Pharmaceuticals Limited

Video analysis: SMSPHARMA.NS

News: SMSPHARMA.NS

Similar companies